Neuland Laboratories Limited

15,590.25

INR
+923.90(+6.30%)
As of November 14, 2024 10:00:00 AM

Valuation Metrics

Market Cap
₹17761.45 Cr
Enterprise Value
₹17876.19 Cr
P/E Ratio (TTM)
52.82
Forward P/E
NA
PEG Ratio
NA
Price to Sales (TTM)
10.86

Financial Metrics

Gross Margin
51.54%
Operating Margin
24.36%
Return on Equity
23.39%
Revenue (TTM)
₹1635.19 Cr+21.099999999999998%
EBITDA
₹501.42 Cr
EPS (TTM)
₹261.83+58.199999999999996%

Balance Sheet

Total Cash
₹87.58 Cr
Total Debt
₹95.39 Cr
Debt to Equity
7.44%

Stock Information

52 Week Range
₹3845 - ₹16524.949
Beta
0.99
Shares Outstanding
₹1.28 Cr

Dividends & Splits

Forward Dividend Yield
0.38%
Trailing Dividend Yield
0.00%
Payout Ratio
3.82%

Neuland Laboratories Limited

15,590.25

INR
+923.90(+6.30%)
As of November 14, 2024 10:00:00 AM

Valuation Metrics

Market Cap
₹17761.45 Cr
Enterprise Value
₹17876.19 Cr
P/E Ratio (TTM)
52.82
Forward P/E
NA
PEG Ratio
NA
Price to Sales (TTM)
10.86

Financial Metrics

Gross Margin
51.54%
Operating Margin
24.36%
Return on Equity
23.39%
Revenue (TTM)
₹1635.19 Cr+21.099999999999998%
EBITDA
₹501.42 Cr
EPS (TTM)
₹261.83+58.199999999999996%

Balance Sheet

Total Cash
₹87.58 Cr
Total Debt
₹95.39 Cr
Debt to Equity
7.44%

Stock Information

52 Week Range
₹3845 - ₹16524.949
Beta
0.99
Shares Outstanding
₹1.28 Cr

Dividends & Splits

Forward Dividend Yield
0.38%
Trailing Dividend Yield
0.00%
Payout Ratio
3.82%